{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:17:01Z","timestamp":1788999421403,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T00:00:00Z","timestamp":1368144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00213-013-3137-2","type":"journal-article","created":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T14:40:19Z","timestamp":1368110419000},"page":"49-55","source":"Crossref","is-referenced-by-count":59,"title":["Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive\u2013compulsive symptoms"],"prefix":"10.1007","volume":"230","author":[{"given":"Jun","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghui","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,10]]},"reference":[{"key":"3137_CR1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00213-004-1847-1","volume":"174","author":"PD Arnold","year":"2004","unstructured":"Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA (2004) Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology (Berl) 174:530\u2013538","journal-title":"Psychopharmacology (Berl)"},{"key":"3137_CR2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archpsyc.63.7.769","volume":"63","author":"PD Arnold","year":"2006","unstructured":"Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL (2006) Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry 63:769\u2013776","journal-title":"Arch Gen Psychiatry"},{"key":"3137_CR3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11682-008-9050-3","volume":"3","author":"PD Arnold","year":"2009","unstructured":"Arnold PD, Macmaster FP, Hanna GL, Richter MA, Sicard T, Burroughs E, Mirza Y, Easter PC, Rose M, Kennedy JL, Rosenberg DR (2009) Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder. Brain Imaging Behav 3:64\u201376","journal-title":"Brain Imaging Behav"},{"key":"3137_CR4","doi-asserted-by":"crossref","unstructured":"Asenjo Lobos C, Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Leucht S (2010) Clozapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev CD006633","DOI":"10.1002\/14651858.CD006633.pub2"},{"key":"3137_CR5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.pnpbp.2006.03.033","volume":"30","author":"M Atmaca","year":"2006","unstructured":"Atmaca M, Yildirim H, Ozdemir H, Aydin A, Tezcan E, Ozler S (2006) Volumetric MRI assessment of brain regions in patients with refractory obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 30:1051\u20131057","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3137_CR6","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1300733","volume":"30","author":"K Chakrabarty","year":"2005","unstructured":"Chakrabarty K, Bhattacharyya S, Christopher R, Khanna S (2005) Glutamatergic dysfunction in OCD. Neuropsychopharmacology 30:1735\u20131740","journal-title":"Neuropsychopharmacology"},{"key":"3137_CR7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/76211","volume":"6","author":"B Conne","year":"2000","unstructured":"Conne B, Stutz A, Vassalli JD (2000) The 3\u2032 untranslated region of messenger RNA: a molecular \u2018hotspot\u2019 for pathology? Nat Med 6:637\u2013641","journal-title":"Nat Med"},{"key":"3137_CR8","doi-asserted-by":"crossref","unstructured":"de Haan L, Linszen DH, Gorsira R (1999) Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. J Clin Psychiatry 60:364\u2013365","DOI":"10.4088\/JCP.v60n0603"},{"key":"3137_CR9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00001756-200403220-00025","volume":"15","author":"R Delorme","year":"2004","unstructured":"Delorme R, Krebs MO, Chabane N, Roy I, Millet B, Mouren-Simeoni MC, Maier W, Bourgeron T, Leboyer M (2004) Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport 15:699\u2013702","journal-title":"Neuroreport"},{"key":"3137_CR10","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/archpsyc.63.7.778","volume":"63","author":"DE Dickel","year":"2006","unstructured":"Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH Jr, Hanna GL (2006) Association testing of the positional and functional candidate gene SLC1A1\/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry 63:778\u2013785","journal-title":"Arch Gen Psychiatry"},{"key":"3137_CR11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1440-1819.2005.01362.x","volume":"59","author":"A Ertugrul","year":"2005","unstructured":"Ertugrul A, Anil Yagcioglu AE, Eni N, Yazici KM (2005) Obsessive-compulsive symptoms in clozapine-treated schizophrenic patients. Psychiatry Clin Neurosci 59:219\u2013222","journal-title":"Psychiatry Clin Neurosci"},{"key":"3137_CR12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/BF01291892","volume":"104","author":"AE Evins","year":"1997","unstructured":"Evins AE, Amico ET, Shih V, Goff DC (1997) Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics. J Neural Transm 104:761\u2013766","journal-title":"J Neural Transm"},{"key":"3137_CR13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1176\/ajp.143.10.1323-a","volume":"143","author":"WS Fenton","year":"1986","unstructured":"Fenton WS, McGlashan TH (1986) The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry 143:437\u2013441","journal-title":"Am J Psychiatry"},{"key":"3137_CR14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS (1989) The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability. Arch Gen Psychiatry 46:1006\u20131011","journal-title":"Arch Gen Psychiatry"},{"key":"3137_CR15","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/bioinformatics\/btf869","volume":"19","author":"LW Hahn","year":"2003","unstructured":"Hahn LW, Ritchie MD, Moore JH (2003) Multifactor dimensionality reduction software for detecting gene\u2013gene and gene\u2013environment interactions. Bioinformatics 19:376\u2013382","journal-title":"Bioinformatics"},{"key":"3137_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.ne.17.030194.000335","volume":"17","author":"M Hollmann","year":"1994","unstructured":"Hollmann M, Heinemann S (1994) Cloned glutamate receptors. Annu Rev Neurosci 17:31\u2013108","journal-title":"Annu Rev Neurosci"},{"key":"3137_CR17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/sj.mp.4000979","volume":"7","author":"S Jamain","year":"2002","unstructured":"Jamain S, Betancur C, Quach H, Philippe A, Fellous M, Giros B, Gillberg C, Leboyer M, Bourgeron T (2002) Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry 7:302\u2013310","journal-title":"Mol Psychiatry"},{"key":"3137_CR18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1440-1819.2005.01373.x","volume":"59","author":"B Kayahan","year":"2005","unstructured":"Kayahan B, Ozturk O, Veznedaroglu B, Eraslan D (2005) Obsessive-compulsive symptoms in schizophrenia: prevalence and clinical correlates. Psychiatry Clin Neurosci 59:291\u2013295","journal-title":"Psychiatry Clin Neurosci"},{"key":"3137_CR19","first-page":"55","volume":"26","author":"A Khullar","year":"2001","unstructured":"Khullar A, Chue P, Tibbo P (2001) Quetiapine and obsessive\u2013compulsive symptoms (OCS): case report and review of atypical antipsychotic-induced OCS. J Psychiatry Neurosci 26:55\u201359","journal-title":"J Psychiatry Neurosci"},{"key":"3137_CR20","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archgenpsychiatry.2009.155","volume":"66","author":"JS Kwon","year":"2009","unstructured":"Kwon JS, Joo YH, Nam HJ, Lim M, Cho EY, Jung MH, Choi JS, Kim B, Kang DH, Oh S, Park T, Hong KS (2009) Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms. Arch Gen Psychiatry 66:1233\u20131241","journal-title":"Arch Gen Psychiatry"},{"key":"3137_CR21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209\u20131223","journal-title":"N Engl J Med"},{"key":"3137_CR22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.pnpbp.2010.02.005","volume":"34","author":"BC Liu","year":"2010","unstructured":"Liu BC, Zhang J, Wang L, Li XW, Wang Y, Ji J, Yang FP, Wan CL, Gao LH, Xu YF, Feng GY, He L, Zhao XZ, He G (2010) No association between EGR gene family polymorphisms and schizophrenia in the Chinese population. Prog Neuropsychopharmacol Biol Psychiatry 34:506\u2013509","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3137_CR23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/1568026799078688","volume":"12","author":"D Marazziti","year":"2012","unstructured":"Marazziti D, Carlini M, Dell'Osso L (2012) Treatment strategies of obsessive-compulsive disorder and panic disorder\/agoraphobia. Curr Top Med Chem 12:238\u2013253","journal-title":"Curr Top Med Chem"},{"key":"3137_CR24","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/appi.ajp.163.4.600","volume":"163","author":"JP McEvoy","year":"2006","unstructured":"McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA, Swartz MS, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK (2006) Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry 163:600\u2013610","journal-title":"Am J Psychiatry"},{"key":"3137_CR25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.schres.2004.08.012","volume":"75","author":"D Ongur","year":"2005","unstructured":"Ongur D, Goff DC (2005) Obsessive\u2013compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status. Schizophr Res 75:349\u2013362","journal-title":"Schizophr Res"},{"key":"3137_CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ajmg.c.30168","volume":"148C","author":"DL Pauls","year":"2008","unstructured":"Pauls DL (2008) The genetics of obsessive compulsive disorder: a review of the evidence. Am J Med Genet C Semin Med Genet 148C:133\u2013139","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"3137_CR27","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00004583-200009000-00008","volume":"39","author":"DR Rosenberg","year":"2000","unstructured":"Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ (2000) Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 39:1096\u20131103","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"3137_CR28","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ajmg.b.31242","volume":"156B","author":"S Ryu","year":"2011","unstructured":"Ryu S, Oh S, Cho EY, Nam HJ, Yoo JH, Park T, Joo YH, Kwon JS, Hong KS (2011) Interaction between genetic variants of DLGAP3 and SLC1A1 affecting the risk of atypical antipsychotics-induced obsessive\u2013compulsive symptoms. Am J Med Genet B Neuropsychiatr Genet 156B:949\u2013959","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"3137_CR29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.comppsych.2008.11.005","volume":"50","author":"AR Sa","year":"2009","unstructured":"Sa AR, Hounie AG, Sampaio AS, Arrais J, Miguel EC, Elkis H (2009) Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol. Compr Psychiatry 50:437\u2013442","journal-title":"Compr Psychiatry"},{"key":"3137_CR30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1755-5949.2009.00130.x","volume":"17","author":"AS Sampaio","year":"2011","unstructured":"Sampaio AS, Fagerness J, Crane J, Leboyer M, Delorme R, Pauls DL, Stewart SE (2011) Association between polymorphisms in GRIK2 gene and obsessive-compulsive disorder: a family-based study. CNS Neurosci Ther 17:141\u2013147","journal-title":"CNS Neurosci Ther"},{"key":"3137_CR31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajmg.b.31184","volume":"156B","author":"J Samuels","year":"2011","unstructured":"Samuels J, Wang Y, Riddle MA, Greenberg BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Grados MA, Knowles JA, Piacentini J, Cullen B, Bienvenu OJ 3rd, Rasmussen SA, Geller D, Pauls DL, Liang KY, Shugart YY, Nestadt G (2011) Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 156B:472\u2013477","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"3137_CR32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/157015912799362724","volume":"10","author":"F Schirmbeck","year":"2012","unstructured":"Schirmbeck F, Zink M (2012) Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review. Curr Neuropharmacol 10:88\u201395","journal-title":"Curr Neuropharmacol"},{"key":"3137_CR33","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1017\/S0033291711000419","volume":"41","author":"F Schirmbeck","year":"2011","unstructured":"Schirmbeck F, Esslinger C, Rausch F, Englisch S, Meyer-Lindenberg A, Zink M (2011) Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. Psychol Med 41:2361\u20132373","journal-title":"Psychol Med"},{"key":"3137_CR34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.cr.7290272","volume":"15","author":"YY Shi","year":"2005","unstructured":"Shi YY, He L (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15:97\u201398","journal-title":"Cell Res"},{"key":"3137_CR35","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/ajmg.b.30533","volume":"144B","author":"SE Stewart","year":"2007","unstructured":"Stewart SE, Fagerness JA, Platko J, Smoller JW, Scharf JM, Illmann C, Jenike E, Chabane N, Leboyer M, Delorme R, Jenike MA, Pauls DL (2007) Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 144B:1027\u20131033","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"3137_CR36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1375\/twin.8.5.450","volume":"8","author":"DS Grootheest van","year":"2005","unstructured":"van Grootheest DS, Cath DC, Beekman AT, Boomsma DI (2005) Twin studies on obsessive\u2013compulsive disorder: a review. Twin Res Hum Genet 8:450\u2013458","journal-title":"Twin Res Hum Genet"},{"key":"3137_CR37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.pbb.2011.10.007","volume":"100","author":"K Wu","year":"2012","unstructured":"Wu K, Hanna GL, Rosenberg DR, Arnold PD (2012) The role of glutamate signaling in the pathogenesis and treatment of obsessive\u2013compulsive disorder. Pharmacol Biochem Behav 100:726\u2013735","journal-title":"Pharmacol Biochem Behav"},{"key":"3137_CR38","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12031-010-9458-2","volume":"43","author":"C Zhang","year":"2011","unstructured":"Zhang C, Li Z, Shao Y, Xie B, Du Y, Fang Y, Yu S (2011) Association study of tryptophan hydroxylase-2 gene in schizophrenia and its clinical features in Chinese Han population. J Mol Neurosci 43:406\u2013411","journal-title":"J Mol Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3137-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-013-3137-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3137-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T16:11:59Z","timestamp":1563034319000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-013-3137-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,10]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["3137"],"URL":"https:\/\/doi.org\/10.1007\/s00213-013-3137-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,10]]}}}